In previous studies evaluating the role of HMGCR in breast cancer, HMGCR expression has consistently been associated with prognostically beneficial tumor characteristics; i.e., low histological grade, expression of estrogen- and progesterone receptors, less axillary lymph node involvement2,15,16. This evidence concerns the gene PGR and breast carcinoma.